Phathom Pharmaceuticals Announces Eligible Commercially Insured Patients May Now Pay as Little as $0 for VOQUEZNA® (vonoprazan) Tablets Exclusively at BlinkRx

Phathom announced that eligible commercially insured patients can pay as little as $0 for VOQUEZNA tablets exclusively through its pharmacy partner BlinkRx, with free home delivery and prior authorization support. The program applies to 30-, 60-, and 90-day fills of VOQUEZNA 10 mg or 20 mg, excludes government-insured patients and Massachusetts residents, and preserves a $55/month cash-pay option.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.